Literature DB >> 26591725

Stage at diagnosis, clinicopathological and treatment patterns of breast cancer at Bugando Medical Centre in north-western Tanzania.

Joseph B Mabula1, Mabula D Mchembe, Phillipo L Chalya, Geofrey Giiti, Alphonce B Chandika, Peter Rambau, Nestory Masalu, Japhet M Gilyomai.   

Abstract

Breast cancer, although reported to be the commonest female malignancy worldwide has not been extensively studied in north-western Tanzania. The aim of this retrospective review was to describe in our setting, the stage at diagnosis, clinicopathological and treatment patterns among patients with breast cancer. Data were analyzed using SPSS software system. A total of 384 patients were studied. The median age was 45 years (range 21 to 78 years). The male to female ratio was 1: 46.8. Most of the patients were premenopausal (63.8%) and presented late with advanced breast cancer disease. Majority of patients (63.0%) presented with stage III disease. Lymph node and distant metastasis at the time of diagnosis was reported in 70.8% and 21.4% of patients, respectively. Invasive ductal carcinoma (91.7%) was the most frequent histopathological type and most patients (63.8%) had poorly differentiated tumour. Patients with tumour size greater than 6cm had significantly high rate of lymph node metastasis (P=0.001) and presence of necrosis within the tumour (P=0.012) compared to patients with tumour size less than 6cm in diameter. Patients younger than 45 years had significantly high rate of lymph node metastasis compared to the patients above this age (P=0.0 11). Mastectomy was the main modality of treatment that was used in 99.5% of the patients. Adjuvant chemotherapy and radiotherapy was reported in 44.8% and 11.7% of patients, respectively. Hormonal therapy (tamoxifen) was given postoperatively to all patients. The overall five-year survival rate was 21.8%. The age of patient at diagnosis, stage of disease, extent of lymph node involvement and histological grade were found to be independent predictors of overall survival rate (P<0.001). Local recurrence was 17.7% and it was significantly related to the stage of disease (P=0.003) and non-adherent to adjuvant therapy (P=0.021). Breast cancer patients in this region are relatively young premenopausal women and mostly present late with advanced stage and high rate of lymph node metastasis. There is need to improve public enlightenment of breast cancer and set up screening centres to encourage early presentations.

Entities:  

Mesh:

Year:  2012        PMID: 26591725

Source DB:  PubMed          Journal:  Tanzan J Health Res        ISSN: 1821-9241


  17 in total

Review 1.  Stage at diagnosis of breast cancer in sub-Saharan Africa: a systematic review and meta-analysis.

Authors:  Elima Jedy-Agba; Valerie McCormack; Clement Adebamowo; Isabel Dos-Santos-Silva
Journal:  Lancet Glob Health       Date:  2016-12       Impact factor: 26.763

2.  Determinants of stage at diagnosis of breast cancer in Nigerian women: sociodemographic, breast cancer awareness, health care access and clinical factors.

Authors:  Elima Jedy-Agba; Valerie McCormack; Oluwole Olaomi; Wunmi Badejo; Monday Yilkudi; Terna Yawe; Emmanuel Ezeome; Iliya Salu; Elijah Miner; Ikechukwu Anosike; Sally N Adebamowo; Benjamin Achusi; Isabel Dos-Santos-Silva; Clement Adebamowo
Journal:  Cancer Causes Control       Date:  2017-04-26       Impact factor: 2.506

3.  Educational Opportunities for Down-Staging Breast Cancer in Low-Income Countries: an Example from Tanzania.

Authors:  Kristen Yang; Khadija Msami; Rose Calixte; Julius Mwaiselage; Joan Dorn; Amr S Soliman
Journal:  J Cancer Educ       Date:  2019-12       Impact factor: 2.037

4.  Invasive breast Cancer treatment in Tanzania: landscape assessment to prepare for implementation of standardized treatment guidelines.

Authors:  Rupali Sood; Nestory Masalu; Roisin M Connolly; Christina A Chao; Lucas Faustine; Cosmas Mbulwa; Benjamin O Anderson; Anne F Rositch
Journal:  BMC Cancer       Date:  2021-05-10       Impact factor: 4.430

5.  Delay in Diagnosis and Treatment of Breast Cancer among Women Attending a Reference Service in Brazil

Authors:  Tiara Cristina Romeiro Lopes; Angela Andréia França Gravena; Marcela de Oliveira Demitto; Deise Helena Pelloso Borghesan; Cátia Millene Dell`Agnolo; Sheila Cristina Rocha Brischiliari; Maria Dalva de Barros Carvalho; Sandra Marisa Pelloso
Journal:  Asian Pac J Cancer Prev       Date:  2017-11-26

6.  Evolutionary aspects of non-metastatic breast cancer after primary treatment in a sub-Saharan African setting: a 16-year retrospective review at the Douala general hospital, Cameroon.

Authors:  Bibiana Ateh Nzeangung; Martin Essomba Biwole; Benjamin Momo Kadia; Ndemazie Nkafu Bechem; Christian Akem Dimala; Albert Mouelle Sone
Journal:  BMC Cancer       Date:  2018-01-05       Impact factor: 4.430

Review 7.  An update on the management of breast cancer in Africa.

Authors:  V Vanderpuye; S Grover; N Hammad; H Simonds; F Olopade; D C Stefan
Journal:  Infect Agent Cancer       Date:  2017-02-14       Impact factor: 2.965

8.  Characterization of hormonal receptors and human epidermal growth factor receptor-2 in tissues of women with breast cancer at Muhimbili National Hospital, Dar es salaam, Tanzania.

Authors:  Amos Rodger Mwakigonja; Nyanda Elias Lushina; Ally Mwanga
Journal:  Infect Agent Cancer       Date:  2017-11-06       Impact factor: 2.965

9.  Survival Outcomes of Breast Cancer in Sudanese Women: A Hospital-Based Study.

Authors:  Hiba F Muddather; Moawia M A Elhassan; Areeg Faggad
Journal:  JCO Glob Oncol       Date:  2021-02

10.  Triple negative breast cancer in a poor resource setting in North-Western Tanzania: a preliminary study of 52 patients.

Authors:  Peter Rambau; Nestory Masalu; Kahima Jackson; Philipo Chalya; Patrizia Serra; Sara Bravaccini
Journal:  BMC Res Notes       Date:  2014-06-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.